Skip to main content

Clearstead Advisors, LLC

SEC CIK
0000842775
Latest filing
Aug 6, 2026

NVS holding history

Novartis AG in every 13F filed by Clearstead Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVS overviewAll 13F holders of NVSFull Q2 2026 holdings

Shares (Q2 2026)
25,239
Value
$3.96M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of NVS by Clearstead Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202625,239$3.96M<0.1%−9,489−27.3%ReducedHolders
Q1 202634,728$5.30M<0.1%+15,598+81.5%AddedHolders
Q4 202519,130$2.64M<0.1%+112+0.6%AddedHolders
Q3 202519,018$2.44M<0.1%−26−0.1%ReducedHolders
Q2 202519,044$2.30M<0.1%+128+0.7%AddedHolders
Q1 202518,916$2.11M<0.1%−107−0.6%ReducedHolders
Q4 202419,023$1.85M<0.1%−628−3.2%ReducedHolders
Q3 202419,651$2.26M<0.1%−2,009−9.3%ReducedHolders
Q2 202421,660$2.31M<0.1%+262+1.2%AddedHolders
Q1 202421,398$2.19M0.1%00.0%UnchangedHolders
Q4 202321,398$2.16M0.1%−1,498−6.5%ReducedHolders
Q3 202322,896$2.33M0.1%+22+0.1%AddedHolders
Q2 202322,874$2.31M0.1%+90+0.4%AddedHolders
Q1 202322,784$2.10M0.2%00.0%UnchangedHolders
Q4 202222,784$2.07M0.2%−1,300−5.4%ReducedHolders
Q3 202224,084$1.83M0.2%−330−1.4%ReducedHolders
Q2 202224,414$2.06M0.2%00.0%UnchangedHolders
Q1 202224,414$2.14M0.1%00.0%UnchangedHolders
Q4 202124,414$2.13M0.1%−304−1.2%ReducedHolders
Q3 202124,718$2.02M0.2%−420−1.7%ReducedHolders
Q2 202125,138$2.29M0.2%−3,061−10.9%ReducedHolders
Q1 202128,199$2.41M0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.